Skip to content

Comparison of the effectiveness of a medical record alert system versus usual care in enhancing bone mineral density screening in patients receiving glucocorticoid therapy, A randomized controlled trial

Comparison of the effectiveness of a medical record alert system versus usual care in enhancing bone mineral density screening in patients receiving glucocorticoid therapy, A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250724003
Enrollment
70
Registered
2025-07-24
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone mineral density screening in patients receiving glucocorticoid therapy Glucocorticoids, Bone mineral density, FRAX score, Vertebral fracture assessment

Interventions

Patients in the intervention group receive alerts directed to their physicians via a medical alert system at each visit, prompting bone mineral density screening, until an appointment is scheduled,The
Experimental Behavioral,No Intervention Behavioral
Medical alert system,Standard care

Sponsors

Department of Medicine, Phramongkutklao Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 20 years or older 2. Currently receiving at least 2.5 mg/day of prednisolone or at least 0.4 mg/day of dexamethasone 3. Receiving prednisolone or dexamethasone continuously for more than 3 months 4. No prior bone mineral density (BMD) assessment 5. No history of osteoporosis treatment (e.g., bisphosphonates, denosumab, calcitonin, or teriparatide)

Exclusion criteria

Exclusion criteria: 1. Prior diagnosis of osteoporosis 2. Pregnancy or breastfeeding 3. Diagnosis of bone cancer or metabolic bone disease 4. Presence of severe comorbid conditions or bedridden status 5. Chronic kidney disease stage 4 or above, or contraindication to osteoporosis medications 6. History of adverse effects or intolerance to osteoporosis treatment 7. Previous referral for or history of bone mineral density testing performed at other hospitals

Design outcomes

Primary

MeasureTime frame
Rate of bone mineral density screening with in 6 months after the first alert the patient scheduled for bone mineral density testing

Secondary

MeasureTime frame
FRAX score assessment every visit FRAX score is a tool used to estimate a person 10-year probability of a major osteoporotic fracture. Note the result in the OPD card,Vertebral assessment every visit plain film spine,Calcium and vitamin D supplement every visit prescribed calcium and vitamin D supplement,Fracture incident every visit X-ray

Countries

Thailand

Contacts

Public ContactKodchapan Angsawetrungruang

Phramongkutklao Hospital

Enjoyyy1996@gmail.com0655329746

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026